Atara Biotherapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATRA and other ETFs, options, and stocks.

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. 

CEO
Pascal Touchon
CEOPascal Touchon
Employees
578
Employees578
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
578
Employees578

ATRA Key Statistics

Market cap
357.63M
Market cap357.63M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.71M
Average volume1.71M
High today
$3.97
High today$3.97
Low today
$3.56
Low today$3.56
Open price
$3.62
Open price$3.62
Volume
1.38M
Volume1.38M
52 Week high
$20.04
52 Week high$20.04
52 Week low
$2.83
52 Week low$2.83

Analyst ratings

60%

of 10 ratings
Buy
60%
Hold
20%
Sell
20%

ATRA Earnings

-$0.98
-$0.65
-$0.33
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.